Pharmacists’ Evolving Role in Electrophysiology Takes Center Stage Ahead of ACC 2026

In this episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, is joined by Kristen Campbell, PharmD, a clinical pharmacist and senior research associate at Duke University, to discuss the evolving role of pharmacists in electrophysiology (EP) care and preview key trials and themes expected at the American College of Cardiology (ACC) 2026 Scientific Session.

Campbell highlights how pharmacists support complex EP care through management of antiarrhythmic therapies, anticoagulation, device-related procedures, and cardiometabolic comorbidities, while playing an expanding role in rhythm-based and ablation-forward strategies. She also previews late-breaking research expected at ACC 2026, including the CHAMPION-AF trial and studies in heart failure with preserved ejection fraction, beta-blocker discontinuation, pulmonary embolism management, and community-based hypertension interventions, underscoring ACC’s value for pharmacists.

Join us for an insightful discussion!